Clinical Trial Update: Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"

View source ↗

Summary

A completed clinical trial update regarding Leuplin PRO for Injection Kit 22.5 mg for prostate cancer, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuplin PRO for Injection Kit 22.5 mg (leuprolide)

Snippet

Sponsor: Takeda | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2019-04-11